Qasim M. Alhadidi

Dr. Qasim M. Alhadidi


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 July 2016 in Nutrition and Cancer
Verified
Journal Article
Closed access
SHSaad Hussain
Saad Hussain
ASAmal A. Sulaiman
Amal A. Sulaiman
CBCurt Balch
Curt Balch
HCHarsh Chauhan
Harsh Chauhan
QAQasim M. Alhadidi
Qasim M. Alhadidi
ATAmit K Tiwari
Amit K Tiwari
Resistance to chemotherapy remains a major impediment to the management of most types of cancer. Both intrinsic and acquired drug resistance are mediated by several cellular and molecular mechanisms, including alternative growth-signaling pathways unaffected by specific therapies, alterations in the tumor microenvironment (e.g., hypoxia and angiogenesis), and active transport of drugs out of the cell. Epidemiological studies have validated an inverse correlation between the consumption of dietary polyphenols and the risk of cancer, which has been attributed to polyphenol antioxidant capacity and their potential to inhibit activation of procarcinogens, cancer cell proliferation, metastasis, and angiogenesis, and inhibition or downregulation of active drug efflux transporters. Moreover, polyphenols can induce apoptosis in cancer cells and modulate immune responses and inflammatory cascades. Augmentation of the efficacy of chemotherapy and prevention of multidrug resistance are other important effects of dietary polyphenols that deserve further research, especially after the discovery of tight “crosstalk” between aberrant growth signaling and metabolic dysfunction in cancer cells. In this review, we cover what is currently known about the role of natural polyphenolic compounds in overcoming cancer drug resistance mediated by diverse primary and secondary resistance mechanisms.

15 December 2015 in Translational Stroke Research
Verified
Journal Article
Closed access
PDF file
QAQasim M. Alhadidi
Qasim M. Alhadidi
MSMuhammad Shahdaat Bin Sayeed
Muhammad Shahdaat Bin Sayeed
Zahoor A. ShahZahoor A. Shah
Zahoor A. Shah

20 December 2014 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
AMAnusha Madineni
Anusha Madineni
QAQasim M. Alhadidi
Qasim M. Alhadidi
Zahoor A. ShahZahoor A. Shah
Zahoor A. Shah

1 January 2016 in Journal of Complementary Medicine Research
Verified
Journal Article
Open access
PDF file
SHSaad Hussain
Saad Hussain
ASAmal Ajaweed Sulaiman
Amal Ajaweed Sulaiman
HAhasan Alhaddad
hasan Alhaddad
QAQasim M. Alhadidi
Qasim M. Alhadidi
Accumulated evidence has focused on the use of natural polyphenolic compounds as nutraceuticals since they showed a wide range of bioactivities and exhibited protection against variety of age-related disorders. Polyphenols have variable potencies to interact, and hence alter the activities of various transporter proteins, many of them classified as anion transporting polypeptide-binding cassette transporters like multidrug resistance protein and p-glycoprotein. Some of the efflux transporters are, generally, linked with anticancer and antiviral drug resistance; in this context, polyphenols may be beneficial in modulating drug resistance by increasing the efficacy of anticancer and antiviral drugs. In addition, these effects were implicated to explain the influence of dietary polyphenols on drug efficacy as result of food-drug interactions. However, limited data are available about the influence of these components on uptake transporters. Therefore, the objective of this article is to review the potential efficacies of polyphenols in modulating the functional integrity of uptake transporter proteins, including those terminated the effect of neurotransmitters, and their possible influence in neuropharmacology.